MajesTEC 4
EMN30/MajesTEC-4: Safety Run-in Data From Phase III Trial of Teclistamab ± Lenalidomide Maintenance Therapy in Newly Diagnosed Multiple Myeloma After ASCT

Released: December 13, 2024

Expiration: December 12, 2025

Activity

Progress
1
Course Completed